TORNTPHARM investors elated by performance

TORRENT PHARMACEUTICALS L showed marginal outperformance today. It increased by +0.62% to close at 1897.75. During the last week it increased by +0.66% and saw a maximum drawdown of -3.13% before bouncing back.

[Themes containing TORNTPHARM]

TORNTPHARM is currently in a bullish trend. The current bullish signal has generated a profit of +13.8% for TORNTPHARM's investors in the last three months.

Trend

Monthly Performance

Alpha (outperformance)

Heatmap

Volatility

Return distribution

TORNTPHARM has been outperforming the NIFTY-50 index in recent time. It showed significant underperformance (compared to the NIFTY-50 index) from 24 Aug, 2016 to 10 Nov, 2017. Over the last 3 years and 1 month, TORNTPHARM underperformed the NIFTY-50 index on 51% days.

During the last three months TORNTPHARM was mostly profitable and delivered on average +0.32% per day. It's best return during this period (of +5.12%) was on Wednesday, 12 Dec, 2018. While it's worst loss in the same period (of -4.77%) was on Friday, 2 Nov, 2018. The longest stort-term trend during this period was 6 profitable days, which started on 22 Nov, 2018 and went on till 30 Nov, 2018. This bullish trend returned +8.38% to investors.

The last 12 months saw TORNTPHARM's investors making profits in 7 months and incurring losses in 5 months. During the last year, TORNTPHARM delivered profits in more months than NIFTY-50 index. TORNTPHARM significantly outperformed NIFTY-50 index in Aug 2018, when it returned +18.59% compared to +6.56% returned by NIFTY-50 index during it's best month in the last one year - Jul 2018. TORNTPHARM and NIFTY-50 index, both had periods of 2 consecutive profitable months. It is interesting to note that both TORNTPHARM and NIFTY-50 index significantly outperform during months when quarterly/annual results are announced.

We make a living by what we get, but we make a life by what we give.
-- Winston Churchill

TORNTPHARM is currently seeing overall fall in volatility. In comparison, the NIFTY-50 index is seeing decrease in volatility. During the last three months, there was a significant fall in TORNTPHARM's volatility from 6 Nov, 2018 to 15 Jan, 2019. While there was a significant fall in the NIFTY-50 index's volatility from 31 Oct, 2018 to 5 Dec, 2018.

Advanced/professional short-term investors should note that TORNTPHARM has negative skewness in it's return distribution. This indicates that investors may need to stay invested through long periods of drawdown before expecting a recovery.

Investors trading in TORNTPHARM derivatives at this moment can consider 'Married Call' options strategy to receive better risk-adjusted returns.

TORNTPHARM has more chance of extreme outcomes than the NIFTY-50 index. Therefore, TORNTPHARM must receive a lower allocation than NIFTY-50 in your portfolio. NIFTY-50 index usually has shorter drawdown period than TORNTPHARM.

Based on your interest in TORNTPHARM you may find it interesting to know that ~MKTCAP201TO250, BAJFINANCE and ~CHEMICALS have all shown remarkable performance and qualify to be on every investor's watchlist.